• |
  • |
  • |
  • |
Donate

Product

Journal: Effects of Metformin Versus Placebo on Children with Fragile X Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Center:
Fiscal Year:
2026
Contact Information:
Product Description:
Metformin may ameliorate hyperactivity and sleep disturbances in children with FXS, with a potential trend toward motor improvement. The favourable safety profile supports further investigation of metformin as a targeted therapy for FXS.
Keyword(s):
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A